ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Outcomes of Highly-Sensitized, Virtual and Flow Cross-Match Negative Renal Transplant Recipients: A Retrospective Observational Study

A. Agrawal1, B. Smith1, M. Gandhi2, C. Schinstock1

1Transplant Nephrology, Mayo Clinic, Rochester, MN, 2Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Meeting: 2022 American Transplant Congress

Abstract number: 1413

Keywords: Antibodies, HLA antibodies, Rejection, Sensitization

Topic: Clinical Science » Kidney » 45 - Kidney Chronic Antibody Mediated Rejection

Session Information

Session Name: Kidney Chronic Antibody Mediated Rejection

Session Type: Poster Abstract

Date: Monday, June 6, 2022

Session Time: 7:00pm-8:00pm

 Presentation Time: 7:00pm-8:00pm

Location: Hynes Halls C & D

*Purpose: Many highly-sensitized kidney transplant recipients are sensitized from prior transplants, which have been shown to limit graft survival more than pregnancy or blood transfusions. Non-HLA donor-specific antibodies (DSAs) may play a role, though their long-term effects have never been examined in this population. Characterizing graft outcomes of highly-sensitized, cross-match negative recipients can elucidate the effect of non-HLA DSAs on allograft survival.

*Methods: We performed a single-center, retrospective, matched cohort study comparing outcomes of kidney transplant recipients with cPRA >/= 90% (n=36) and cPRA = 0% (n=36). Patients were matched by age and donor type. Those with pretransplant DSA and de novo DSA (defined as MFI>1000) were excluded, after reviewing LABSCREEN single antigen bead testing and flow cytometric results with our HLA laboratory. Surveillance biopsies and de novo DSA screening were performed 4, 12, 24 and 60 months post-transplant. We used Banff 2019 criteria (except for DSA) for the histologic diagnosis of ABMR. Non-HLA antibodies were not tested for.

*Results: Baseline characteristics were similar among the matched cohorts. The median (IQR) age was 46.0 (34.7, 55.4); 80.6% were Caucasian, and 62.5% received a deceased donor kidney transplant. 52.8% of patients with cPRA>/= 90% were female, compared to 33.3% in the cPRA = 0% cohort (p=0.10). Despite having no pretransplant DSA, recipients with a cPRA >/= 90% had a higher incidence of histologic features suggestive of active antibody-mediated rejection (ABMR) (30.6% (11/36) versus 11.1% (4/36), p=0.04) over a median (IQR) follow-up time of 3.2 (2.2, 3.9) years post-transplant. Glomerulitis and peritubular capillaritis were the predominant histologic features of ABMR. While no patient with cPRA >/= 90% and histologic features of ABMR developed de novo DSA, all patients with active ABMR in the cPRA = 0% group developed de novo DSA. Death-censored allograft survival was lower among patients with a cPRA >/= 90% (88.9% versus 97.2%), though not statistically significant (p=0.16).

*Conclusions: Highly-sensitized transplant recipients have a higher incidence of histologic features of ABMR, even in the absence of anti-HLA DSA. Non-HLA DSAs may play a larger role than previously accredited, though further work is needed to characterize their mechanisms of injury and impact on long-term allograft survival.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Agrawal A, Smith B, Gandhi M, Schinstock C. Outcomes of Highly-Sensitized, Virtual and Flow Cross-Match Negative Renal Transplant Recipients: A Retrospective Observational Study [abstract]. Am J Transplant. 2022; 22 (suppl 3). https://atcmeetingabstracts.com/abstract/outcomes-of-highly-sensitized-virtual-and-flow-cross-match-negative-renal-transplant-recipients-a-retrospective-observational-study/. Accessed May 30, 2025.

« Back to 2022 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences